Maricann Group (CNSX:MARI) had its price target decreased by stock analysts at Canaccord Genuity from $4.25 to $3.75 in a research note issued on Monday. Canaccord Genuity’s price target points to a potential upside of 65.93% from the company’s current price.
Shares of CNSX MARI opened at $2.26 on Monday. Maricann Group has a 52-week low of $0.87 and a 52-week high of $3.60.
Maricann Group Company Profile
Maricann Group Inc, formerly Danbel Industries Corporation, is a Canada-based integrated producer and distributor of marijuana for medical purposes. As one of approximately 43 companies with a federal license to cultivate cannabis and one of approximately 30 independent licensed producers with a federal license to process and distribute cannabis, the Company’s services a patient base with more than 8,000 registered patients.
Further Reading: Do Tariffs Work?
Receive News & Ratings for Maricann Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maricann Group and related companies with MarketBeat.com's FREE daily email newsletter.